Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

iRhythm Technologies  (Stock symbol: IRTC )

699 8th Street Ste. 600
San Francisco, CA 94103
Website Company Summary Management Team

CEO: Quentin Blackford (09/25/2021)
President/COO/Operations: Judy Lenane (7/08)
General Management: Sharon Tracy (4/30/2019) ; Liana Hennum (2/28/2018)
Finance: Brice Bobzien (07/26/2022) ; Douglas Devine (6/8/2020)
Technology: Allan Wilsker (1/31/2012) ; Mark Day (11/30/2008)
Business Development: Chad Patterson

Outside board: (May no longer be on the board) Casper De Clercq (Norwest Venture Partners Venture Partner) Mark J Rubash (Eventbrite CFO) Joshua L Green (Mohr, Davidow Ventures) William N Starling (Synergy Life Science Partners Managing Director) Vijay Lathi (Leapfrog Ventures Managing Director) Raymond W Scott (Axolotl Former CEO) Chris Grant (Kaiser Permanente National Venture Development Executive Managing Director) Tiba Aynechi (Novo Ventures Partner)
Former outside board: Roberta Reiff Katz (Stanford University VP Strategic Planning) R Hardwin Mead (Sequoia Hospital cardiologist) Sam Brasch (Kaiser Permanente Ventures)

Business description: iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias. We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.

Rounds: 6
Recent Fundings: May 2014   Apr 2013
Capital raised: 122.8M
Last Round: 17.0M
Ownership: Public   Ipo Filing
Stock Symbol: IRTC
VCs include: Mohr, Davidow VenturesNorwest Venture PartnersSt. Jude Medical ;  Novo A/S;  New Leaf Venture Partners Synergy Life Science Partners;  California HealthCare Foundation ;  UNC Kenan-Flagler Private Equity Fund

Last Tweets


Last Mentions

Record updated: Jul 2022
Sector: Medical
Year Founded: 2006
Headcount: 1601-2000 as of Jul 2022
Rounds: 6
Recent Fundings: May 2014   Apr 2013
Capital Raised: 122.8M
Last Round: 17.0M
Ownership: Public   Ipo Filing
Stock Symbol: IRTC